GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Middle East Healthcare Co (SAU:4009) » Definitions » Research & Development

Middle East Healthcare Co (SAU:4009) Research & Development : ﷼0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Middle East Healthcare Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Middle East Healthcare Co's Research & Development for the three months ended in Mar. 2024 was ﷼0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ﷼0 Mil.


Middle East Healthcare Co Research & Development Historical Data

The historical data trend for Middle East Healthcare Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Middle East Healthcare Co Research & Development Chart

Middle East Healthcare Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only - - - - -

Middle East Healthcare Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Middle East Healthcare Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Middle East Healthcare Co  (SAU:4009) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Middle East Healthcare Co Research & Development Related Terms

Thank you for viewing the detailed overview of Middle East Healthcare Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Middle East Healthcare Co (SAU:4009) Business Description

Traded in Other Exchanges
N/A
Address
4, Batterjee Road, P.O.Box 2550, Al-Zahra District, Jeddah, SAU, 21461
Middle East Healthcare Co is a Saudi Arabia-based company engaged in the business of managing, operating and maintaining hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, pharmacies, construction and to buy land for the purpose of constructing medical projects and to establish, manage and organize exhibitions for the company.

Middle East Healthcare Co (SAU:4009) Headlines

No Headlines